Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 984 entries
View as:

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01964963 Org: User:
Start: 08/03/11 End: 07/31/17 Due: 07/31/18

A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

Phase: N/A Priority: Normal
NCT ID: NCT05886478 Org: User:
Start: 02/08/24 End: 10/31/24 Due: 10/31/25

TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02723201 Org: User:
Start: 04/28/16 End: 08/24/16 Due: 08/24/17

Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)

Phase: N/A Priority: Normal
NCT ID: NCT02415712 Org: User:
Start: 01/27/15 End: 06/30/22 Due: 06/30/23

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Phase: N/A Priority: Normal
NCT ID: NCT02425098 Org: User:
Start: 06/03/15 End: 09/18/17 Due: 09/18/18

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01456247 Org: User:
Start: 03/31/12 End: 10/31/13 Due: 10/31/14

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT02072330 Org: User:
Start: 03/31/13 End: 12/31/13 Due: 12/31/14

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

Phase: N/A Priority: Normal
NCT ID: NCT02381288 Org: User:
Start: 09/10/15 End: 04/08/16 Due: 04/08/17

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"

Phase: N/A Priority: Normal
NCT ID: NCT03555591 Org: User:
Start: 05/01/16 End: 10/31/21 Due: 10/31/22

A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT04392648 Org: User:
Start: 06/24/20 End: 11/10/23 Due: 11/10/24

A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

Phase: N/A Priority: Normal
NCT ID: NCT03296787 Org: User:
Start: 11/21/17 End: 08/09/19 Due: 08/09/20

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00696436 Org: User:
Start: 04/30/08 End: 08/31/09 Due: 08/31/10

Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02559713 Org: User:
Start: 11/29/17 End: 02/22/19 Due: 02/22/20

Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01452724 Org: User:
Start: 10/31/11 End: 02/28/13 Due: 02/28/14

A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

Phase: N/A Priority: Normal
NCT ID: NCT05084053 Org: User:
Start: 01/19/22 End: 10/31/25 Due: 10/31/26

Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01834274 Org: User:
Start: 06/30/13 End: 03/31/14 Due: 03/31/15

A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02427958 Org: User:
Start: 08/07/15 End: 11/23/18 Due: 11/23/19

Post Marketing Surveillance Study for ADYNOVATE in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT03824522 Org: User:
Start: 02/25/19 End: 01/05/24 Due: 01/05/25

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01318109 Org: User:
Start: 08/31/08 End: 04/30/09 Due: 04/30/10

A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT04840680 Org: User:
Start: 03/22/21 End: 08/28/23 Due: 08/28/24

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06233461 Org: User:
Start: 03/05/24 End: 07/23/27 Due: 07/23/28

Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.

Phase: N/A Priority: Normal
NCT ID: NCT02457247 Org: User:
Start: 06/30/15 End: 08/31/15 Due: 08/31/16

Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02024971 Org: User:
Start: 07/31/10 End: 11/30/13 Due: 11/30/14

A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04971525 Org: User:
Start: 04/03/23 End: 11/13/26 Due: 11/13/27

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06562543 Org: User:
Start: 01/14/25 End: 10/04/27 Due: 10/04/28